[The influence of the beta-mimetic Ritodrine on the potassium balance under tocolytic therapy (author's transl)].
A time-dependent picture was to be obtained of the potassium concentration by means of a continual determination in serum, urine and red cells during tocolytic therapy with beta-mimetic drugs for inhibiting premature uterine activity. The results obtained under bulk tocolysis with Ritodrine (Prepar) infusions and after a twelve-hour interval of strict food deprivation, speak in favour of a rise in potassium elimination via the urine, and, therefore, of a substitution, contrary to the opinion held until now.
D005260:Female; D006801:Humans; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011188:Potassium / Q000378:metabolism*; D011247:Pregnancy; D011412:Propanolamines / Q000494:pharmacology*; D012312:Ritodrine / Q000494:pharmacology*; D013997:Time Factors; D014590:Uterine Contraction / Q000187:drug effects*
D011412:Propanolamines; D012312:Ritodrine; D011188:Potassium
Der Einfluss des Betamimetikums Ritodrine auf den Kaliumhaushalt unter tokolytischer Therapie.